Skip to content

Strategy on endometrial preparation of frozen-thawed embryo transfer in patients with active endometriosis

Strategy on endometrial preparation of frozen-thawed embryo transfer in patients with active endometriosis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17010800
Enrollment
Unknown
Registered
2017-03-06
Start date
2017-03-06
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility

Interventions

GnRHa+HRT-FET:GnRHa+HRT-FET
NC/LE/HMG/HRT-FET:NC/LE/HMG/HRT-FET

Sponsors

The Shanghai Ninth People's Hospital affiliated of Shanghai JiaoTong University of medical school
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 38 Years

Inclusion criteria

Inclusion criteria: 1. patients with active endometriosis aged 20-38 years; 2. more than 2D3 high-quality embryos frozen (=2D3 6 cell grade I and II) or a blastocyst (4BB and above); 3. clinical manifestations and auxiliary examination of active endometriosis: (1) endometriotic cysts recurrence after laparoscopy or laparotomy before IVF; (2) increased dysmenorrhea or tenderness nodules by gynecological examination after endometriotic cysts surgery by laparoscopy or laparotomy before IVF; (3) increased CA125 after endometriotic cysts surgery by laparoscopy or laparotomy before IVF; (4) ovarian endometriomas that were aspirated and identified as multiple chocolate cysts (=1-3cm) or a single chocolate cyst(=3cm)(unilateral or bilateral) during ovulation monitoring or at the time of oocyte retrieval.

Exclusion criteria

Exclusion criteria: 1. Hydrosalpinx; 2. polycystic ovarian syndrome (PCOS); 3. adenomyosis (AM) diagnosed by laparoscopic or laparotomy or disordered myometrial echo confirmed by ultrasound examination, mild adenomyosis by MRI diagnosis; 4. uterine malformations; 5. severe intrauterine adhesions; 6. endometrium thickness <7mm on transplantation day; 7. recurrent abortions =3; 8. clinically significant systemic disease such as renal failure.

Design outcomes

Primary

MeasureTime frame
clinical pregnancy rate;implantation rate;cancellation rate;live birth rate;

Secondary

MeasureTime frame
cumulative pregnancy rate;abortion rate;ectopic rate;multiple pregnancy rate;average number of visits;

Countries

China

Contacts

Public ContactYanping Kuang

Shanghai Nineth People's Hospital

kuangyanp@126.com+86 021-53078080

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026